Physiological and self-reported effects of Kombucha on well-being, induced stress, and inflammation

Aberystwyth University0 个研究点目标入组 60 人开始时间: 2024年3月6日最近更新: 2024年3月18日

适应症

试验速览

暂无简介。

•1. Subjects over 18 years of age and under 60 years of age
•2. Subjects who are able to commit to multiple visits to WARU
•3. Subjects who can provide venous blood samples, urine samples, and saliva samples
•4. Subjects able to provide written informed consent prior to performing any study procedures

•1. Subjects with a diagnosis of Alzheimer’s disease or other forms of dementia
•2. Subjects taking medication for the treatment of dementia (such as acetylcholinesterase inhibitors (Aricept, Excelon), memantine (Namenda) or other medications with similar mechanisms of action) or medical foods (such as Cerefolin, Souvenaid, Axona) for the treatment of dementia.
•3. Subjects who are pregnant or lactating
•4. Subjects with medical condition or disease that is life-threatening
•5. Subjects diagnosed with diabetes.
•6. Subjects already consuming pro-biotics who will not comply with the 4-week washout
•7. Subjects with any cardiovascular diseases
•8. Subjects with severe physical illnesses (e.g., fibromyalgia)
•9. Subjects experiencing hypertension (high blood pressure)
•10. Subjects with endocrine disorders
•11. Subjects suffering from substance abuse
•12. Subjects who heavily smoke (>10 cigarettes/day)
•13. Any medication known to affect the HPA axis.

发起方